Lab News
Market for COVID-19 diagnostics to hit $38B by year end
February 26, 2021 -- As the unfortunate milestone of one full year of the global COVID-19 pandemic worldwide is reached, the diagnostic industry has been changed, perhaps permanently. Bruce Carlson of Kalorama Information discusses how COVID-19 testing has quickly risen to rival other more established segments of the IVD market. Read More
Thermo Fisher completes Mesa Biotech acquisition
February 26, 2021 -- Thermo Fisher Scientific has completed its previously announced acquisition of point-of-care molecular diagnostics provider Mesa Biotech. Read More
Vela Diagnostics adds 2 SARS-CoV-2 assays
February 26, 2021 -- Vela Diagnostics has added two SARS-CoV-2 assays to its portfolio: ViroKey SQ Flex SARS-CoV-2 genotyping and ViroKey SARS-CoV-2 ID reverse transcription polymerase chain reaction. Read More
BrainChip, NaNose laud progress in breath sample COVID-19 test
February 25, 2021 -- BrainChip and NaNose Medical announced that they are making progress on a COVID-19 test kit that uses artificial intelligence to analyze exhaled breath samples. Read More
CRISPR assay as good as PCR for detecting SARS-CoV-2 infections
February 24, 2021 -- CRISPR-based methods appear to offer reliable SARS-CoV-2 testing and screening as efficiently as polymerase chain reaction (PCR) techniques, potentially making it possible to capture the leading edge of an outbreak using less expensive technology. Read More
Qiagen, Inovio to partner on cervical dysplasia test
February 24, 2021 -- Qiagen and Inovio have announced they will develop a next-generation sequencing test for HPV-linked advanced cervical dysplasia that can be used on Illumina's NextSeq 550Dx platform. Read More
GenesisCare, Prelude partner on breast cancer test
February 24, 2021 -- GenesisCare and Prelude have partnered on an early-stage breast cancer test for women diagnosed with ductal carcinoma in situ or stage 0 cancer and who are being treated with breast-conserving surgery. Read More
Grail teams with Quest on blood test for early cancer detection
February 23, 2021 -- Cancer diagnostics startup Grail has signed Quest Diagnostics to provide phlebotomy services for its upcoming Galleri multicancer early detection blood test. Read More
PerkinElmer unveils COVID-19 rapid antigen test
February 23, 2021 -- PerkinElmer has launched a lateral-flow immunoassay COVID-19 antigen test, a rapid antigen test suitable for mass COVID-19 screening or for diagnosis of asymptomatic or symptomatic individuals. Read More
FDA releases new guidance for developers of COVID-19 products
February 23, 2021 -- The U.S. Food and Drug Administration (FDA) has released new guidance for developers of products for COVID-19 diagnostics, vaccines, and treatments, with a particular emphasis on addressing coronavirus variants. Read More
Connect
LabPulse on LinkedIn
LabPulse on Facebook
LabPulse on Twitter
Latest Tweets